Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients
Go back to Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients| INDIA GLOBALIZATION CAPITAL, Inc. (NYSE: IGC) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $0.83 | |||
| Open | $0.30 | 52 Week Low | $0.15 | |||
| Day High | $0.30 | P/E | N/A | |||
| Day Low | $0.30 | EPS | $-0.48 | |||
| Volume | 9,896 | |||||
